Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.950
+0.040 (1.02%)
Nov 21, 2024, 12:24 PM EST - Market open
Xenetic Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Xenetic Biosciences.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for XBIO is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +912.66% | Apr 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +912.66% | May 2, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $50 | Strong Buy | Maintains | $20 → $50 | +1,165.82% | Jan 11, 2021 |
Financial Forecast
Revenue This Year
2.24M
from 2.54M
Decreased by -11.65%
Revenue Next Year
1.84M
from 2.24M
Decreased by -18.18%
EPS This Year
-1.03
from -2.71
EPS Next Year
-0.67
from -1.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.3M | 1.9M | 2.4M |
| Avg | 2.2M | 1.8M | 2.3M |
| Low | 2.2M | 1.8M | 2.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -9.1% | -15.8% | 31.5% |
| Avg | -11.7% | -18.2% | 27.8% |
| Low | -15.1% | -21.4% | 22.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.06 | -0.69 | -0.67 |
| Avg | -1.03 | -0.67 | -0.65 |
| Low | -0.99 | -0.65 | -0.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.